Improving HPV vaccine uptake in underserved populations

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention focuses on educating underserved populations about the importance of the HPV vaccine through workshops led by trained Community Health Educators. Participants will receive educational materials developed by the National Cancer Institute, including presentations and videos, aimed at adolescents and young adults who have not started or completed the HPV vaccine series. The study will assess the effectiveness of this educational intervention using pre- and post-tests, as well as follow-up surveys to track vaccination rates and referrals to care. The goal is to enhance knowledge and increase the completion rates of the HPV vaccine among participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Be a Denver Health patient\* 18-26 years old, who has not started or completed the HPV vaccine series (Vaccine completion for this age group is 3 doses).
2. Be a parent of a Denver Health adolescent patient\* aged 9-17 years old, who has not started or completed the HPV vaccine series. (Vaccine completion is 2 doses for 9-14-year-old, and 3 doses for 14-17-year old)
3. English and/or Spanish Speaking
4. Stated willingness to comply with all study procedures and be available for the duration of the study

   * Denver Health patients will be identified from one of the following clinics; Denver Health Clinics Eastside Adult Clinic, Eastside Women's Care Clinic, Westside Adult Clinic, Westside Women's Care Clinic, Pavilion C: Women's Care Clinic, La Casa-Quigg Newton Family Health Center, Lowry Family Health Center, Montbello Family Health Center, Westwood Family Health Center, Parkhill Family Health Center, Webb Center For Primary Care, Pena Southwest Clinic

Exclusion Criteria:

1. Individuals who do not meet eligibility criteria, including individuals who do not speak English or Spanish \[at the discretion of the CHE or PN upon recruitment\]
2. Decisionally-challenged adults with cognitive or personality impairment or due to intoxication (alcohol or drugs) that might interfere with their ability to consent or participate in the study \[at the discretion of the CHE or PN upon recruitment\]
3. Individuals from vulnerable populations (e.g., inmates, homeless, pregnant women, and those with auditory impairment \[at the discretion of the CHE or PN upon recruitment\]
4. Individuals under the age of 18 years.

Where it's running

• University of Colorado Hospital
  Denver, Colorado, United States Recruiting

Study contacts

• Principal investigator: Evelinn Borrayo — University of Colorado, Denver
• Study coordinator: Sindy Gonzalez
• Email: Sindy.Gonzalez@CUAnschutz.edu
• Phone: 303-724-5445

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HPV self-sampling in the ED to screen under-screened women

  This study tests whether giving an HPV self-sampling kit in the emergency department can help under-screened women get screened for cervical cancer and find those with HPV to guide follow-up care.

  Recruiting Rutgers, The State University of New Jersey · New Brunswick, New Jersey and 1 other locations · NCT07657104

• CHW4CervixHealth: HPV self-collection kits with community health workers

  This project will test whether giving self-collection HPV kits during community workshops led by community health workers helps increase screening among under-screened women aged 25–65 and will first compare kit results to clinical Pap smears.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07336134

• Preventing cervical cancer with rapid HPV genotyping and same-day self-sampling

  This project tests whether a rapid HPV genotyping test on self-collected and provider-collected samples can quickly identify women at high risk so they can receive same-day screening and treatment in low-resource settings.

  Recruiting at 4 sites Atila Biosystems Inc. · Sunnyvale, California and 3 other locations · NCT07232355

• Lidocaine injection before surgery for oropharyngeal cancer

  This study tests if giving a lidocaine injection before surgery can help improve outcomes for patients with oropharyngeal cancer.

  Recruiting Phase 1 Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania · NCT06747390

• High resolution anal examination for HPV and anal cancer detection

  This study is testing how well high-resolution anal exams can help find high-risk HPV and anal cancer in people who are more likely to have these issues.

  Recruiting Universitair Ziekenhuis Brussel · Jette · NCT06697964

• Evaluating the Gardasil HPV vaccine's immune responses in people with and without HIV

  This study is testing how well the Gardasil HPV vaccine works in people born male, both with and without HIV, to see how their immune systems respond to the vaccine.

  Recruiting Phase 2 University of Maryland, Baltimore · Washington D.C., District of Columbia and 1 other locations · NCT06624839

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.